Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Size By Application, Industry Analysis Report, Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Recession Impact Analysis)
ID : MRU_
50007 | Date :
Jan, 2023 | Pages :
182 | Region : Global |
Publisher : RI
HPV infections can infect the genital areas of men including the skin on and around the penis or anus. These infections can also be spread to the mouth and the throat. According to CDC, about 1% of sexually active men in the U.S. have genital warts at any given time. Even when HPV infections are persistent to the male population and can cause severe diseases such as genital warts, anal cancers, penile cancers, and cancers of the oropharynx, there is currently no HPV test recommend for men. The approved tests available in the market are for screening women for cervical cancers. They are not useful for the screening of HPV-related cancers or genital warts in men. The selective product availability has restricted the growth of the market to a specific gender leading to slow growth over the forecast period.
The Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market size was xxx million USD with a CAGR xx % from 2018-2022. It will stretch to xxx million USD in 2023 with a CAGR of xx % from 2023-2030.
As the report focuses on global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market, mainly in Europe and Asia Pacific, North America, Middle East and Africa, and South America. This report segmented the Market on the basis of regions, manufacturers, applications, and type.
in addition, this report introduces Market competition situation among the vendors and company profile, besides, Market price analysis and value chain features are covered in this report.
In Market segmentation by manufacturers, the report covers the following companies-
F. Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
Becton, Dickinson and Company
Qiagen N.V.
Thermo Fisher Scientific Inc.
Abbott Laboratories
Hologic Inc.
Cepheid Inc.
Seegene Inc.
Takara Bio Inc.
DaAn Gene Co., Ltd. of Sun Yat-Sen University
Promega Corporation
Greiner Bio-One International GmbH (Greiner Holding AG)
Enzo Biochem Inc.
Norgen Biotek Corp.
DiagCor Bioscience Inc Ltd
Hybribio Limited
Zytovision GmbH
Arbor Vita Corporation
Medical & Biological Laboratories Co., Ltd
Fujirebio Diagnostics, Inc.
In Market segmentation by geographical regions, the report has analyzed the following regions- North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types covers:
Services
Assay kits
System
In Market segmentation by applications :
Hosptial
Clinic
Apart from the drivers, restraints, and opportunities, the report also offers competitive landscape, including various growth strategies adopted by profiled players for establishing significant position in the industry. The segmentation included in the comprehensive report will help respectable manufacturers to set up their processing units in the regions and increase their global presence. This would also benefit the industry and increase the company\'s product portfolio.
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market for the forecast period 2023-2030?
• What are the driving forces in the Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market for the forecast period 2023-2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Molecular Human Papillomavirus (HPV) Diagnostic Equipment industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Size Growth Rate by Type (2020-2030)
1.3.2 Services
1.3.3 Assay kits
1.3.4 System
1.4 Market Segment by Application
1.4.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Share by Application (2020-2030)
1.4.2 Hosptial
1.4.3 Clinic
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value 2015-2030
2.1.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production 2015-2030
2.1.3 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Capacity 2015-2030
2.1.4 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2020-2030
2.2.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Size CAGR of Key Regions
2.2.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Capacity by Manufacturers
3.1.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue by Manufacturers (2018-2022)
3.2.2 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue Share by Manufacturers (2018-2022)
3.2.3 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Concentration Ratio (CR5 and HHI)
3.3 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Price by Manufacturers
3.4 Key Manufacturers Molecular Human Papillomavirus (HPV) Diagnostic Equipment Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market
3.6 Key Manufacturers Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Services Production and Production Value (2018-2022)
4.1.2 Assay kits Production and Production Value (2018-2022)
4.1.3 System Production and Production Value (2018-2022)
4.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Market Share by Type
4.3 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Market Share by Type
4.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
6 Production by Regions
6.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production (History Data) by Regions 2015-2020
6.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Growth Rate 2015-2020
6.3.2 United States Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Growth Rate 2015-2020
6.3.3 Key Players in United States
6.3.4 United States Molecular Human Papillomavirus (HPV) Diagnostic Equipment Import & Export
6.4 European Union
6.4.1 European Union Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Growth Rate 2015-2020
6.4.2 European Union Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Growth Rate 2015-2020
6.4.3 Key Players in European Union
6.4.4 European Union Molecular Human Papillomavirus (HPV) Diagnostic Equipment Import & Export
6.5 China
6.5.1 China Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Growth Rate 2015-2020
6.5.2 China Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Growth Rate 2015-2020
6.5.3 Key Players in China
6.5.4 China Molecular Human Papillomavirus (HPV) Diagnostic Equipment Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Regions
7.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Type
7.2.2 United States Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
7.3 European Union
7.3.1 European Union Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Type
7.3.2 European Union Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
7.4 China
7.4.1 China Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Type
7.4.2 China Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Type
7.5.2 Rest of World Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 F. Hoffmann-La Roche Ltd.
8.1.1 F. Hoffmann-La Roche Ltd. Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.1.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.1.5 F. Hoffmann-La Roche Ltd. Recent Development
8.2 Agilent Technologies, Inc.
8.2.1 Agilent Technologies, Inc. Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.2.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.2.5 Agilent Technologies, Inc. Recent Development
8.3 Becton, Dickinson and Company
8.3.1 Becton, Dickinson and Company Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.3.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.3.5 Becton, Dickinson and Company Recent Development
8.4 Qiagen N.V.
8.4.1 Qiagen N.V. Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.4.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.4.5 Qiagen N.V. Recent Development
8.5 Thermo Fisher Scientific Inc.
8.5.1 Thermo Fisher Scientific Inc. Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.5.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.5.5 Thermo Fisher Scientific Inc. Recent Development
8.6 Abbott Laboratories
8.6.1 Abbott Laboratories Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.6.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.6.5 Abbott Laboratories Recent Development
8.7 Hologic Inc.
8.7.1 Hologic Inc. Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.7.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.7.5 Hologic Inc. Recent Development
8.8 Cepheid Inc.
8.8.1 Cepheid Inc. Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.8.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.8.5 Cepheid Inc. Recent Development
8.9 Seegene Inc.
8.9.1 Seegene Inc. Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.9.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.9.5 Seegene Inc. Recent Development
8.10 Takara Bio Inc.
8.10.1 Takara Bio Inc. Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.10.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.10.5 Takara Bio Inc. Recent Development
8.11 DaAn Gene Co., Ltd. of Sun Yat-Sen University
8.12 Promega Corporation
8.13 Greiner Bio-One International GmbH (Greiner Holding AG)
8.14 Enzo Biochem Inc.
8.15 Norgen Biotek Corp.
8.16 DiagCor Bioscience Inc Ltd
8.17 Hybribio Limited
8.18 Zytovision GmbH
8.19 Arbor Vita Corporation
8.20 Medical & Biological Laboratories Co., Ltd
8.21 Fujirebio Diagnostics, Inc.
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Capacity, Production Forecast 2020-2030
9.1.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Forecast 2020-2030
9.2 Market Forecast by Regions
9.2.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production and Value Forecast by Regions 2020-2030
9.2.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption Forecast by Regions 2020-2030
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Forecast by Type
9.7.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales Channels
10.2.2 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Distributors
10.3 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porters Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.